Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Aparna Annam

Concepts (122)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Radiography, Interventional
4
2024
128
1.830
Why?
Radiology
3
2022
175
1.080
Why?
Thrombolytic Therapy
2
2024
165
0.800
Why?
Thrombectomy
1
2024
79
0.790
Why?
Radiologists
2
2022
61
0.730
Why?
Endovascular Procedures
2
2024
390
0.720
Why?
Hepatic Veins
1
2021
28
0.690
Why?
Patient Advocacy
1
2022
73
0.680
Why?
Vascular Malformations
1
2021
53
0.650
Why?
Professional Role
1
2022
172
0.640
Why?
Portal Vein
1
2021
123
0.620
Why?
Venous Thromboembolism
1
2024
332
0.600
Why?
Radiology, Interventional
3
2023
49
0.490
Why?
Wounds and Injuries
2
2022
959
0.490
Why?
Spermatocele
1
2015
2
0.440
Why?
Scrotum
1
2015
25
0.430
Why?
Pediatrics
3
2023
1124
0.430
Why?
International Educational Exchange
1
2014
9
0.420
Why?
Testis
1
2015
158
0.420
Why?
Testicular Neoplasms
1
2015
108
0.400
Why?
Ultrasonography
2
2022
788
0.360
Why?
Fibrinolytic Agents
3
2024
303
0.330
Why?
Global Health
1
2014
403
0.330
Why?
Education, Medical, Graduate
2
2023
568
0.320
Why?
Child
15
2024
22693
0.320
Why?
Infant, Newborn
8
2024
6460
0.310
Why?
Anticoagulants
2
2024
746
0.280
Why?
Age Factors
3
2024
3347
0.270
Why?
Infant
7
2024
10114
0.250
Why?
Child, Preschool
8
2024
11913
0.240
Why?
Postthrombotic Syndrome
1
2024
13
0.210
Why?
Humans
24
2024
146342
0.200
Why?
Vascular System Injuries
1
2024
79
0.190
Why?
Treatment Outcome
5
2024
11821
0.190
Why?
Risk Factors
4
2024
10921
0.180
Why?
Respiratory Distress Syndrome, Newborn
1
2023
104
0.180
Why?
Noonan Syndrome
1
2022
14
0.180
Why?
Neonatology
1
2022
36
0.180
Why?
Splenectomy
1
2022
61
0.180
Why?
Embolization, Therapeutic
2
2022
246
0.180
Why?
Venous Thrombosis
1
2024
199
0.170
Why?
Adolescent
7
2024
22557
0.170
Why?
Pulmonary Embolism
1
2024
246
0.170
Why?
Hepatopulmonary Syndrome
1
2021
23
0.170
Why?
Nephrostomy, Percutaneous
1
2021
11
0.160
Why?
Quality Indicators, Health Care
2
2021
343
0.160
Why?
Expert Testimony
1
2021
43
0.160
Why?
Cholecystostomy
1
2020
4
0.160
Why?
Urinary Catheterization
1
2021
35
0.160
Why?
Urologic Diseases
1
2021
44
0.160
Why?
Point-of-Care Systems
1
2022
185
0.160
Why?
Needs Assessment
1
2023
404
0.160
Why?
Biliary Tract Surgical Procedures
1
2020
26
0.160
Why?
Education, Medical
1
2023
274
0.160
Why?
Spleen
1
2022
503
0.150
Why?
Empyema, Pleural
1
2019
13
0.150
Why?
Chest Tubes
1
2019
32
0.150
Why?
Sclerotherapy
1
2018
18
0.140
Why?
Hemangioma
1
2019
46
0.140
Why?
Lymphatic Abnormalities
1
2018
20
0.140
Why?
Doxycycline
1
2018
61
0.140
Why?
Bronchitis
1
2017
28
0.130
Why?
Extracorporeal Membrane Oxygenation
1
2021
370
0.130
Why?
Secondary Prevention
1
2018
248
0.120
Why?
Biomedical Research
1
2023
729
0.120
Why?
Lung Diseases
1
2022
787
0.110
Why?
Lymphatic Diseases
1
2014
21
0.110
Why?
Lymphography
1
2014
13
0.110
Why?
Quality Improvement
2
2021
1354
0.110
Why?
Liver Transplantation
1
2021
751
0.110
Why?
Disease Management
1
2019
651
0.100
Why?
Volunteers
1
2014
40
0.100
Why?
Lymphatic Vessels
1
2014
64
0.100
Why?
Internship and Residency
1
2023
1281
0.090
Why?
Male
7
2024
73396
0.090
Why?
Skin Neoplasms
1
2019
806
0.080
Why?
Antineoplastic Agents
1
2022
2219
0.080
Why?
Practice Guidelines as Topic
1
2019
1591
0.080
Why?
Diagnosis, Differential
1
2015
1503
0.080
Why?
Postoperative Complications
1
2021
3034
0.070
Why?
Consensus
2
2021
467
0.070
Why?
Lung
1
2022
4122
0.070
Why?
Magnetic Resonance Imaging
2
2018
3926
0.060
Why?
Feasibility Studies
2
2022
1135
0.050
Why?
Neonatologists
1
2022
12
0.050
Why?
Blood Coagulation
1
2024
267
0.050
Why?
Mitogen-Activated Protein Kinase Kinases
1
2022
126
0.040
Why?
False Positive Reactions
1
2022
124
0.040
Why?
Administration, Oral
1
2024
872
0.040
Why?
Dyspnea
1
2023
251
0.040
Why?
Pyrimidinones
1
2022
124
0.040
Why?
Female
4
2024
79499
0.040
Why?
Retrospective Studies
4
2022
17438
0.040
Why?
Pyridones
1
2022
210
0.040
Why?
Thrombosis
1
2024
398
0.040
Why?
Thoracotomy
1
2019
87
0.040
Why?
Thoracic Surgery, Video-Assisted
1
2019
55
0.040
Why?
Intensive Care Units, Neonatal
1
2022
295
0.040
Why?
Trauma Centers
1
2022
441
0.040
Why?
Abdominal Cavity
1
2018
5
0.040
Why?
Hemorrhage
1
2024
825
0.040
Why?
Drainage
1
2019
187
0.030
Why?
Extravasation of Diagnostic and Therapeutic Materials
1
2018
20
0.030
Why?
Thoracic Duct
1
2017
6
0.030
Why?
Ultrasonography, Interventional
1
2018
163
0.030
Why?
Sensitivity and Specificity
1
2022
1998
0.030
Why?
Patient Safety
1
2020
352
0.030
Why?
Combined Modality Therapy
1
2019
1271
0.030
Why?
Recurrence
1
2018
1133
0.030
Why?
Injections, Intralesional
1
2014
34
0.030
Why?
Gadolinium DTPA
1
2014
70
0.030
Why?
Length of Stay
1
2019
1358
0.020
Why?
Pandemics
1
2022
1707
0.020
Why?
Altitude
1
2017
469
0.020
Why?
Contrast Media
1
2014
493
0.020
Why?
Tomography, X-Ray Computed
1
2022
2786
0.020
Why?
Surveys and Questionnaires
1
2023
6073
0.020
Why?
Prospective Studies
1
2022
8123
0.020
Why?
Follow-Up Studies
1
2018
5439
0.020
Why?
United States
1
2022
16136
0.010
Why?
Young Adult
1
2014
14330
0.010
Why?
Adult
1
2014
41087
0.010
Why?
Annam's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)